SCHEMBL30616129

SCHEMBL30616129

CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.65
▸ LGALS3 P17931 4/20 0.59
▸ LGALS8 O00214 1/20 0.59
▸ LGALS4 P56470 1/20 0.59
▸ CD69 Q07108 1/20 0.54
▸ ALDH1A1 P00352 2/20 0.53
▸ THRB P10828 1/20 0.53
▸ CHIA Q9BZP6 1/20 0.45
▸ FGF1 P05230 1/20 0.45
▸ FGF2 P09038 1/20 0.45
▸ VEGFA P15692 1/20 0.45
▸ HPSE Q9Y251 1/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ LGALS1 P09382 1/20 0.45
▸ LGALS7; LGALS7B P47929 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13479975 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL29401541 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL31682911 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL5514293 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL7720011 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL6820124 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL5518959 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL3229913 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL10488345 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69
SCHEMBL29456417 1.00 MAPK1 (0.65) MAPK1LGALS3LGALS8LGALS4CD69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023209068-A1 PERSONALIZED ANTICANCER VACCINE COMPRISING GLYCOENGINEERED TUMOUR CELLS OR TUMOUR CELL FRAGMENTS CARBOCALYX GMBH (DE) 2023-11-02 — — WO claimed
WO-2023209068-A1 PERSONALIZED ANTICANCER VACCINE COMPRISING GLYCOENGINEERED TUMOUR CELLS OR TUMOUR CELL FRAGMENTS CARBOCALYX GMBH (DE) 2023-11-02 — — WO disclosed
Send feedback